Ardelyx
ARDX
$6.61
Share price
3.28%
Change (1 day)
42.15%
Change (1 year)
Categories
Ardelyx (ARDX) - Cash on Hand
Cash on Hand as of December 2023 : $0.18 B
According to Ardelyx's latest financial reports the company has $0.18 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Ardelyx - Cash on Hand chart (from 2013 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.18 B | 48.74% |
| 2022-12-31 | $0.12 B | 6.19% |
| 2021-12-31 | $0.11 B | -37.43% |
| 2020-12-31 | $0.18 B | -24.66% |
| 2019-12-31 | $0.24 B | 47.25% |
| 2018-12-31 | $0.16 B | 25.46% |
| 2017-12-31 | $0.13 B | -33.29% |
| 2016-12-31 | $0.20 B | 87.68% |
| 2015-12-31 | $0.10 B | -0.26% |
| 2014-12-31 | $0.10 B | 211.56% |
| 2013-12-31 | $34.43 M | 4.66% |
| 2012-12-31 | $32.9 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Abbott Laboratories ABT | $7.27 B | 3,849.56% | 🇺🇸 USA |
 Amgen AMGN | $10.94 B | 5,838.18% | 🇺🇸 USA |
 Sanofi SNY | $9.92 B | 5,286.97% | 🇫🇷 France |
 AstraZeneca AZN | $8.02 B | 4,252.17% | 🇬🇧 UK |
 OPKO Health
OPK | $95.88 M | -47.98% | 🇺🇸 USA |